EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy
JJ Kang, A Ko, SH Kil, JMS Clair, DS Shin… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Receptor tyrosine kinases (RTKs) are cell surface receptors that bind growth factor ligands
and initiate cellular signaling. Of the 20 classes of RTKs, 7 classes, IV, VIII, and X, are linked …
and initiate cellular signaling. Of the 20 classes of RTKs, 7 classes, IV, VIII, and X, are linked …
EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy
JJ Kang, A Ko, SH Kil… - … et biophysica acta …, 2023 - pubmed.ncbi.nlm.nih.gov
Receptor tyrosine kinases (RTKs) are cell surface receptors that bind growth factor ligands
and initiate cellular signaling. Of the 20 classes of RTKs, 7 classes, IV, VIII, and X, are linked …
and initiate cellular signaling. Of the 20 classes of RTKs, 7 classes, IV, VIII, and X, are linked …
EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy.
JJ Kang, A Ko, SH Kil, JM Clair, DS Shin… - … et Biophysica acta …, 2022 - europepmc.org
Receptor tyrosine kinases (RTKs) are cell surface receptors that bind growth factor ligands
and initiate cellular signaling. Of the 20 classes of RTKs, 7 classes, IV, VIII, and X, are linked …
and initiate cellular signaling. Of the 20 classes of RTKs, 7 classes, IV, VIII, and X, are linked …